受强制性开放获取政策约束的文章 - Weixiao Dai了解详情
可在其他位置公开访问的文章：4 篇
Improving traditional registrational trial end points: development and application of a desirability of outcome ranking end point for complicated urinary tract infection …
J Howard-Anderson, T Hamasaki, W Dai, D Collyar, D Rubin, S Nambiar, ...
Clinical Infectious Diseases 76 (3), e1157-e1165, 2023
强制性开放获取政策： US Department of Energy, US National Institutes of Health
Efficacy and safety of azithromycin versus placebo to treat lower respiratory tract infections associated with low procalcitonin: a randomised, placebo-controlled, double-blind …
EL Tsalik, NG Rouphael, RT Sadikot, MC Rodriguez-Barradas, ...
The Lancet Infectious Diseases 23 (4), 484-495, 2023
强制性开放获取政策： US National Institutes of Health, US Department of Veterans Affairs
Characteristics of community-acquired carbapenem-resistant Enterobacterales
R Shrestha, CL Luterbach, W Dai, L Komarow, M Earley, G Weston, ...
Journal of antimicrobial chemotherapy 77 (10), 2763-2771, 2022
强制性开放获取政策： US National Institutes of Health
A desirability of outcome ranking analysis of a randomized clinical trial comparing seven versus fourteen days of antibiotics for uncomplicated gram-negative bloodstream infection
J Howard-Anderson, W Dai, D Yahav, T Hamasaki, A Turjeman, F Koppel, ...
Open forum infectious diseases 9 (6), ofac140, 2022
强制性开放获取政策： US National Institutes of Health
出版信息和资助信息由计算机程序自动确定